Skip to content

Clinical trials

Phase 1/2 Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 1/2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20161
20191
20201
20211
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Unknown status3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China Medical University Hospital1
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia1
Guy's and St Thomas' NHS Foundation Trust1
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus1
Nanfang Hospital, Southern Medical University1
Nuwacell Biotechnologies Co., Ltd.1
Shandong Cancer Hospital and Institute1
Shanghai East Hospital1
University Hospital, Tours1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial12
COVID-192
Sarcoidosis, Pulmonary2
Bronchiolitis Obliterans1
Connective Tissue Diseases1
Coronavirus Infections1
Granuloma1
Hypertension, Pulmonary1
Idiopathic Interstitial Pneumonias1
Idiopathic Pulmonary Fibrosis1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.